医保谈判药“双通道”政策管理模式及优化建议  

"Dual channel"policy management model and optimization suggestions for medical insurance negotiation drugs

作　　者：徐鑫 王守涛 杨郁葱 XU Xin;WANG Shoutao;YANG Yucong(Benxi Central Hosptial,Benxi,Liaoning Province,117000,PRC)

机构地区：[1]本溪市中心医院,辽宁省本溪市117000

出　　处：《中国医院》2023年第9期75-77,共3页Chinese Hospitals

摘　　要：近年来,国家医保药品谈判工作日益完善,医保目录准入速度大幅提高。为破解国家医保谈判药品“进院难”现象、最大程度提高其可及性,国家医疗保障局、国家卫生健康委联合发布“双通道”管理机制。本文分析了“双通道”的政策背景现状、必要性和三方联动管理机制,并以本溪市中心医院为例分析实施现状和启示。医保部门、医疗机构和定点药房三方默契配合、紧密协作、实现合力互补,规范药品流通和使用,能更好释放前期谈判所获得的政策红利,不断增强人民群众的就医获得感。In recent years,the national medical insurance drug negotiation work has been increasingly improved,and the speed of access to the medical insurance catalog has been greatly increased.To solve the problem of"difficult access to hospitals"for national medical insurance negotiated drugs and maximize their accessibility,the National Medical Security Bureau and the National Health Commission jointly issued a"dual channel"management mechanism.This article analyzes the policy background,necessity,and three-party linkage management mechanism of the"dual channel",and takes Benxi Central Hospital as an example to analyze the implementation status and enlightenment.The three parties of the medical insurance department,medical institutions,and designated pharmacies cooperate closely and complement each other's strengths,regulate drug circulation and use,can better release the policy dividends obtained from the previous negotiations,and continuously enhance the people's sense of obtaining medical treatment.

关 键 词：双通道 管理模式 医保部门 医疗机构 定点药店 

分 类 号：R197[医药卫生—卫生事业管理]